Nutrien Ltd. (NYSE:NTR) Shares Sold by Shufro Rose & Co. LLC

Shufro Rose & Co. LLC reduced its stake in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 1.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 75,728 shares of the company’s stock after selling 1,200 shares during the quarter. Shufro Rose & Co. LLC’s holdings in Nutrien were worth $4,677,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. First Pacific Financial boosted its holdings in Nutrien by 1.7% during the fourth quarter. First Pacific Financial now owns 12,399 shares of the company’s stock worth $699,000 after buying an additional 206 shares in the last quarter. Ascent Wealth Partners LLC increased its position in Nutrien by 2.1% during the third quarter. Ascent Wealth Partners LLC now owns 12,300 shares of the company’s stock worth $760,000 after purchasing an additional 250 shares during the last quarter. Ruggaard & Associates LLC increased its position in Nutrien by 4.7% during the third quarter. Ruggaard & Associates LLC now owns 5,848 shares of the company’s stock worth $361,000 after purchasing an additional 260 shares during the last quarter. Shell Asset Management Co. grew its stake in Nutrien by 0.7% during the third quarter. Shell Asset Management Co. now owns 50,043 shares of the company’s stock worth $3,100,000 after buying an additional 337 shares during the period. Finally, Meixler Investment Management Ltd. grew its stake in Nutrien by 8.7% during the third quarter. Meixler Investment Management Ltd. now owns 4,201 shares of the company’s stock worth $259,000 after buying an additional 338 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Stock Up 1.0 %

Shares of NYSE NTR traded up $0.50 during trading hours on Friday, hitting $52.55. The company had a trading volume of 1,227,851 shares, compared to its average volume of 1,711,381. The firm’s 50 day moving average is $53.23 and its 200-day moving average is $54.03. Nutrien Ltd. has a 1-year low of $47.90 and a 1-year high of $70.07. The stock has a market capitalization of $25.99 billion, a P/E ratio of 20.77, a price-to-earnings-growth ratio of 1.96 and a beta of 0.89. The company has a quick ratio of 0.65, a current ratio of 1.17 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTRGet Free Report) last posted its earnings results on Wednesday, February 21st. The company reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.35). Nutrien had a return on equity of 8.59% and a net margin of 4.33%. The firm had revenue of $5.66 billion for the quarter, compared to analyst estimates of $5.36 billion. During the same period in the prior year, the business posted $2.02 EPS. The firm’s quarterly revenue was down 24.8% compared to the same quarter last year. On average, analysts expect that Nutrien Ltd. will post 3.82 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, March 28th were issued a dividend of $0.54 per share. This is a boost from Nutrien’s previous quarterly dividend of $0.53. This represents a $2.16 annualized dividend and a dividend yield of 4.11%. The ex-dividend date was Wednesday, March 27th. Nutrien’s payout ratio is 85.38%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Wells Fargo & Company decreased their target price on shares of Nutrien from $77.00 to $69.00 and set an “overweight” rating for the company in a research note on Monday, February 26th. The Goldman Sachs Group cut their price objective on shares of Nutrien from $88.00 to $78.00 and set a “buy” rating on the stock in a research report on Thursday, February 1st. TD Securities cut their price objective on shares of Nutrien from $75.00 to $67.00 and set a “buy” rating on the stock in a research report on Tuesday, February 20th. JPMorgan Chase & Co. downgraded shares of Nutrien from a “neutral” rating to an “underweight” rating and dropped their price target for the stock from $58.00 to $48.00 in a research report on Friday, February 23rd. Finally, Jefferies Financial Group began coverage on shares of Nutrien in a research note on Tuesday, March 26th. They issued a “buy” rating and a $62.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $67.95.

View Our Latest Analysis on NTR

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.